Stock Market Reviews

Read and share opinions on ZVRA (Zevra Therapeutics, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market

Latest News

• Analysts Have Lowered Expectations For Zevra Therapeutics, Inc. (NASDAQ:ZVRA) After Its Latest Results
  Nov 8, 2025
• Zevra Therapeutics Inc (ZVRA) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ...
  Nov 6, 2025
• Zevra Therapeutics (ZVRA) Reports Q3 Loss, Lags Revenue Estimates
  Nov 5, 2025
• Zevra Therapeutics: Q3 Earnings Snapshot
  Nov 5, 2025
• Zevra Reports Third Quarter 2025 Financial Results and Corporate Update
  Nov 5, 2025
• Zevra Therapeutics to Participate in the Guggenheim Healthcare Innovation Conference
  Oct 29, 2025
• Zevra Therapeutics Announces Details for Q3 2025 Financial Results Call
  Oct 27, 2025
• Zevra Therapeutics (ZVRA) Surges 12.3%: Is This an Indication of Further Gains?
  Oct 16, 2025
• Zevra Therapeutics (ZVRA): Evaluating Valuation Following Insider Buying and Sustained Revenue Growth
  Oct 10, 2025
• Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
  Oct 6, 2025
• Zevra Therapeutics (ZVRA) Soars 10.4%: Is Further Upside Left in the Stock?
  Sep 25, 2025
• Zevra Therapeutics Announces Upcoming Oral Presentation at the International Niemann-Pick Disease Alliance (INPDA) Meeting and Poster Presentations at the Child Neurology Society (CNS) Conference on MIPLYFFA® (arimoclomol) and OLPRUVA® (sodium phenylbutyrate)
  Sep 18, 2025
• Zevra Therapeutics (ZVRA) Announces Positive New Data Supporting Foundational Role of MIPLYFFA® for the Treatment of Niemann-Pick Disease Type C
  Sep 17, 2025
• A Fresh Look at Zevra Therapeutics (ZVRA) Valuation Following New MIPLYFFA Data Release
  Sep 16, 2025
• Alvin Shih Adds To Zevra Therapeutics Holding
  Sep 16, 2025